The CRISPR Journal: Does the scientific community need another niche science journal?
Zayani Bhatt, 26 Sep 2017 In February 2018, there will soon be a new journal dedicated to CRISPR technology. It hopes that the editorials, analyses, debates and commentary surrounding the technology could drive more ground-breaking research to transform human lives. But critics have questioned over the necessity of another niche science journal. Will it stand out from existing major journals?
Treating diseases with electrical impulses: A possible alternative in the near future?
Leon Kan, 19 Sep 2017 Nerve stimulation via controlled electrical impulses while strong in theory have had limited practical implementations in the medical field. That is, until now. Invigorated by multi-million dollar investments, electroceuticals have now been shocked to life — and could serve as an alternative for the future medical treatment.
FDA to enforce regulatory framework over stem cell market
Rachel Seah, 14 Sep 2017 The US Food and Drug Administration (FDA) is increasing enforcement against clinics, which are unscrupulously administering unproven and potentially harmful ‘stem cell treatments’ to unsuspecting patients.
Watson for the cure of cancer: The search continues
Leon Kan, 12 Sep 2017 IBM’s Watson Health was introduced to the healthcare industry three years ago. Since then, it has been working to improve the standards of healthcare worldwide including, its biggest challenge – the cure for cancer.